Skip to search formSkip to main contentSkip to account menu

Troxatyl

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
BackgroundGemcitabine, a deoxycytidine nucleoside analog, is the current standard chemotherapy used as first-line treatment for… 
2005
2005
BACKGROUND Troxacitabine (Troxatyl) is a novel L-enantiomer nucleoside analog with activity in pancreatic cancer xenograft models… 
2003
2003
PurposeTroxacitabine (BCH-4556, l-(−)-OddC, Troxatyl) is a novel β-l-nucleoside analogue with potent antineoplastic activity both… 
2003
2003
PURPOSE A multi-institution phase II study was undertaken by National Cancer Institute of Canada-Clinical Trials Group to… 
Review
2002
Review
2002
The treatment options for chronic myelogenous leukemia (CML) continue to evolve rapidly. Imatinib mesylate (Gleevec, Glivec… 
2002
2002
Abstract Purpose. We have recently identified a deoxycytidine nucleoside analogue, troxacitabine (β-L-dioxolane cytidine… 
2002
2002
PURPOSE Troxacitabine (Troxatyl, BCH-4556; BioChem Pharma Inc, Basingstoke, United Kingdom) is a novel synthetic L-nucleoside… 
Review
2002
Review
2002
  • F. Giles
  • Expert review of anticancer therapy
  • 2002
  • Corpus ID: 42920941
Unique among currently approved or in-development nucleoside analogs, troxacitabine (Troxatyl™) is an L-nucleoside with… 
Highly Cited
2001
Highly Cited
2001
Troxacitabine (Troxatyl; BCH-4556; (-)-2'-deoxy-3'-oxacytidine), a deoxycytidine analogue with an unusual dioxolane structure and… 
2000
2000
Abstract.Purpose: Troxacitabine (β-L-dioxolane cytidine, BCH-4556; Troxatyl, BioChem Pharma Inc.) is a novel nucleoside analogue…